RCUS
$22.12-3.07%
RCUS financial statements
The full income statement, balance sheet, and cash-flow statement for Arcus Biosciences Inc. (RCUS), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 91.4M2024-09 91.5M2024-12 105.8M2025-03 105.9M2025-06 106.4M2025-09 108.0M2025-12 125.3M2026-03 125.8M2026-06 127.3M+39.3% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 247M-4.3% | 258M+597.3% | 37.0M-2.6% | 38.0M-90.1% | 383M+391.0% | |
| 633M+7.7% | 588M+28.7% | 457M+16.6% | 392M+19.1% | 329M+62.9% | ||
| Research & development | 523M+16.7% | 448M+31.8% | 340M+18.1% | 288M+12.1% | 257M+61.6% | |
| Selling, general & administrative | 110M-8.3% | 120M+2.6% | 117M+12.5% | 104M+44.4% | 72.0M+67.4% | |
| General & administrative | 110M-8.3% | 120M+2.6% | 117M+12.5% | 104M+44.4% | 72.0M+67.4% | |
| Operating income | -386M-17.0% | -330M+2.9% | -340M-21.4% | -280M-618.5% | 54.0M+143.5% | |
| Interest expense | 8.00M+100.0% | 4.00M+100.0% | 2.00M+0.0% | 2.00M | — | |
| Other non-operating income | 33.0M-31.3% | 48.0M+23.1% | 39.0M+178.6% | 14.0M+1300.0% | 1.00M+0.0% | |
| Pre-tax income | -353M-25.2% | -282M+6.3% | -301M-13.2% | -266M-583.6% | 55.0M+144.7% | |
| Income tax | 0.00-100.0% | 1.00M-83.3% | 6.00M+500.0% | 1.00M-50.0% | 2.00M | |
| Net income | -353M-24.7% | -283M+7.8% | -307M-15.0% | -267M-603.8% | 53.0M+143.1% | |
| -$3.29-4.8% | -$3.14+24.3% | -$4.15-11.9% | -$3.71-622.5% | $0.71+131.7% | ||
| EPS (basic) | -$3.29-4.8% | -$3.14+24.3% | -$4.15-11.9% | -$3.71-588.2% | $0.76+133.9% | |
| Weighted-avg shares (basic) | 107M+19.2% | 90.1M+21.8% | 74.0M+2.8% | 72.0M+3.9% | 69.3M+26.5% | |
| Weighted-avg shares (diluted) | 107M+19.2% | 90.1M+21.8% | 74.0M+2.8% | 72.0M-2.7% | 74.0M+35.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.01B-0.9% | 1.02B+22.3% | 831M-22.1% | 1.07B-15.5% | 1.26B+71.5% | ||
| Cash & equivalents | 222M+48.0% | 150M+18.1% | 127M-38.3% | 206M+39.2% | 148M-14.7% | |
| Prepaid expenses | 15.0M-16.7% | 18.0M-47.1% | 34.0M+78.9% | 19.0M+5.6% | 18.0M+229.0% | |
| 1.14B-1.0% | 1.15B+5.0% | 1.09B-18.6% | 1.34B-15.5% | 1.59B+106.1% | ||
| Property, plant & equipment | 40.0M-14.9% | 47.0M-7.8% | 51.0M+45.7% | 35.0M+9.4% | 32.0M+196.1% | |
| Operating lease right-of-use | 58.0M-10.8% | 65.0M-29.3% | 92.0M-8.0% | 100M-4.8% | 105M+721.5% | |
| Other non-current assets | 63.0M-13.7% | 73.0M-31.1% | 106M-7.0% | 114M-1.7% | 116M+1757.2% | |
| 231M+2.2% | 226M+22.8% | 184M-4.7% | 193M+16.3% | 166M+36.4% | ||
| Accounts payable | 42.0M+133.3% | 18.0M+5.9% | 17.0M-15.0% | 20.0M+100.0% | 10.0M-36.2% | |
| Accrued liabilities | — | — | — | — | 24.2M+153.4% | |
| Deferred revenue | 35.0M-58.8% | 85.0M-6.6% | 91.0M-6.2% | 97.0M-4.9% | 102M+36.8% | |
| Current lease liability | 13.0M+8.3% | 12.0M+9.1% | 11.0M+266.7% | 3.00M-41.2% | 5.10M+77.9% | |
| Other current liabilities | 154M+25.2% | 123M+61.8% | 76.0M+0.0% | 76.0M+40.7% | 54.0M+1414.3% | |
| — | — | — | — | 750M+178.0% | ||
| Long-term debt | 99.0M+106.3% | 48.0M | 0.00 | — | — | |
| Deferred revenue (non-current) | 43.0M-81.6% | 234M-23.8% | 307M-13.5% | 355M-23.2% | 462M+248.6% | |
| Non-current lease liability | 86.0M-13.1% | 99.0M-10.0% | 110M-6.0% | 117M+0.0% | 117M+667.6% | |
| Operating lease liability (total) | 99.0M-10.8% | 111M-8.3% | 121M-4.0% | 126M+11.0% | 114M+527.0% | |
| Other non-current liabilities | 135M-14.0% | 157M+10.6% | 142M+1.4% | 140M+14.8% | 122M+22367.8% | |
| 631M+30.1% | 485M+5.0% | 462M-29.7% | 657M-22.0% | 842M+67.7% | ||
| Preferred stock | — | — | — | 0.00 | 0.00 | |
| Common stock | 2.12B+30.9% | 1.62B+23.3% | 1.31B+8.7% | 1.21B | — | |
| Additional paid-in capital | — | — | — | — | 1.12B+34.6% | |
| Retained earnings | -1.49B-31.2% | -1.13B-33.3% | -849M-56.6% | -542M-97.1% | -275M+16.2% | |
| Accumulated other comprehensive income | 0.00 | — | 0.00+100.0% | -7.00M-600.0% | -1.00M-2372.7% | |
| Total liabilities & equity | 1.14B-1.0% | 1.15B+5.0% | 1.09B-18.6% | 1.34B-15.5% | 1.59B+106.1% | |
| Common shares issued | 125M+35.9% | 92.2M+22.1% | 75.5M+3.6% | 72.9M+3.0% | 70.8M+8.7% | |
| Common shares outstanding | 125M+35.9% | 92.2M+22.1% | 75.5M+3.6% | 72.9M+3.0% | 70.8M+8.7% | |
| Shares outstanding (cover) | 125M+18.4% | 106M+16.5% | 90.9M+24.5% | 73.0M+2.7% | 71.1M+0.3% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -482M-183.5% | -170M+44.4% | -306M-169.9% | 438M+271.1% | -256M-330.6% | ||
| Depreciation & amortization | 10.0M+0.0% | 10.0M+25.0% | 8.00M+33.3% | 6.00M+50.0% | 4.00M+33.3% | |
| Share-based compensation | 60.0M-21.1% | 76.0M+4.1% | 73.0M+12.3% | 65.0M+18.2% | 55.0M+150.0% | |
| Change in payables | 24.0M+700.0% | 3.00M+400.0% | -1.00M-112.5% | 8.00M+260.0% | -5.00M-155.6% | |
| Other operating activities | 1.00M-66.7% | 3.00M+50.0% | 2.00M-33.3% | 3.00M | 0.00 | |
| 66.0M+178.6% | -84.0M-143.3% | 194M+147.0% | -413M-10225.0% | -4.00M+99.1% | ||
| Capital expenditure | 2.00M-66.7% | 6.00M-75.0% | 24.0M+300.0% | 6.00M-76.9% | 26.0M+766.7% | |
| Free cash flow | -484M-175.0% | -176M+46.7% | -330M-176.4% | 432M+253.2% | -282M-361.1% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchases of investments | — | — | — | — | 719M-2.8% | |
| Sales/maturities of investments | — | — | — | — | 690M+124.5% | |
| Other investing activities | — | 0.00 | 0.00-100.0% | 3.00M | — | |
| 488M+76.2% | 277M+739.4% | 33.0M+0.0% | 33.0M-86.1% | 237M-46.0% | ||
| Long-term debt issued | 49.0M+4.3% | 47.0M | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 429M+88.2% | 228M+812.0% | 25.0M | 0.00-100.0% | 220M-49.3% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 72.0M+213.0% | 23.0M+129.1% | -79.0M-236.2% | 58.0M+352.2% | -23.0M-119.8% | |
| Interest paid | 7.00M+600.0% | 1.00M | 0.00 | 0.00 | — | |
| Income taxes paid | 0.00 | 0.00-100.0% | 5.00M+66.7% | 3.00M | 0.00 | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 2.99B+89.5% | 1.58B+10.2% | 1.43B-4.5% | 1.50B-47.9% | 2.88B+56.3% | |
| P/E | — | — | — | 18.8×-65.3% | 54.3× | |
| P/S | 12.1×+98.0% | 6.1×-80.3% | 31.1×+798.0% | 3.5×-53.9% | 7.5×-68.2% | |
| P/B | 4.7×+45.7% | 3.2×+18.2% | 2.7×+28.4% | 2.1×-37.3% | 3.4×-6.8% | |
| P/FCF | — | — | — | 3.5× | — | |
| Earnings yield | — | — | — | 5.3%+188.2% | 1.8% | |
| FCF yield | — | — | — | 28.8% | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: RCUS’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all RCUS filings on SEC EDGAR → Not investment advice.